Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Ghadimi

Showing results (181-190 of 280) with videos related to

Pageof 28
Sort By:
Plos One|April 12, 2016
Heterogeneity of KRAS Mutation Status in Rectal CancerPeter Jo, Alexander König, Markus Schirmer, et al.
Journal of Clinical Medicine|March 6, 2019
Lack of an Association between the Functional Polymorphism TREM-1 rs2234237 and the Clinical Course of Sepsis among Critically Ill Caucasian Patients-A Monocentric Prospective Genetic Association StudyJulius Runzheimer, Caspar Mewes, Benedikt Büttner, et al.
NPJ Precision Oncology|October 14, 2023
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancerDavid Digomann, Max Heiduk, Charlotte Reiche, et al.
Therapeutic Advances in Gastroenterology|February 18, 2022
Effectiveness of fourth-line dual immunotherapy in hepatocellular carcinoma with simultaneous steroid administration for immune-related hepatitisKristina Lowes, Johanna Reinecke, Marius Brunner, et al.
Cancer Research|March 5, 2008
Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genomeJordi Camps, Marian Grade, Quang Tri Nguyen, et al.
Journal of Clinical Medicine|January 13, 2019
CTLA-4 Genetic Variants Predict Survival in Patients with SepsisCaspar Mewes, Benedikt Büttner, José Hinz, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 16, 2020
Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer - Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological SocietyUlrike Irmgard Attenberger, Stephan Clasen, Michael Ghadimi, et al.
Annals of Surgery|September 30, 2022
Pelvic Intraoperative Neuromonitoring Prevents Dysfunction in Patients With Rectal Cancer: Results From a Multicenter, Randomized, Controlled Clinical Trial of a NEUROmonitoring System (NEUROS)Werner Kneist, Michael Ghadimi, Norbert Runkel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 15, 2011
Comparison of the micronucleus and chromosome aberration techniques for the documentation of cytogenetic damage in radiochemotherapy-treated patients with rectal cancerHendrik Andreas Wolff, Steffen Hennies, Markus Karl Alfred Herrmann, et al.
Case Reports in Gastroenterology|March 30, 2022
Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and TrastuzumabSebastian Schade, Ute Koenig, Ardian Mekolli, et al.
Pageof 28

Showing results (181-190 of 280) with videos related to

Sort By:
Pageof 28
Plos One|April 12, 2016
Heterogeneity of KRAS Mutation Status in Rectal CancerPeter Jo, Alexander König, Markus Schirmer, et al.
Journal of Clinical Medicine|March 6, 2019
Lack of an Association between the Functional Polymorphism TREM-1 rs2234237 and the Clinical Course of Sepsis among Critically Ill Caucasian Patients-A Monocentric Prospective Genetic Association StudyJulius Runzheimer, Caspar Mewes, Benedikt Büttner, et al.
NPJ Precision Oncology|October 14, 2023
Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancerDavid Digomann, Max Heiduk, Charlotte Reiche, et al.
Therapeutic Advances in Gastroenterology|February 18, 2022
Effectiveness of fourth-line dual immunotherapy in hepatocellular carcinoma with simultaneous steroid administration for immune-related hepatitisKristina Lowes, Johanna Reinecke, Marius Brunner, et al.
Cancer Research|March 5, 2008
Chromosomal breakpoints in primary colon cancer cluster at sites of structural variants in the genomeJordi Camps, Marian Grade, Quang Tri Nguyen, et al.
Journal of Clinical Medicine|January 13, 2019
CTLA-4 Genetic Variants Predict Survival in Patients with SepsisCaspar Mewes, Benedikt Büttner, José Hinz, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|December 16, 2020
Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer - Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological SocietyUlrike Irmgard Attenberger, Stephan Clasen, Michael Ghadimi, et al.
Annals of Surgery|September 30, 2022
Pelvic Intraoperative Neuromonitoring Prevents Dysfunction in Patients With Rectal Cancer: Results From a Multicenter, Randomized, Controlled Clinical Trial of a NEUROmonitoring System (NEUROS)Werner Kneist, Michael Ghadimi, Norbert Runkel, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|January 15, 2011
Comparison of the micronucleus and chromosome aberration techniques for the documentation of cytogenetic damage in radiochemotherapy-treated patients with rectal cancerHendrik Andreas Wolff, Steffen Hennies, Markus Karl Alfred Herrmann, et al.
Case Reports in Gastroenterology|March 30, 2022
Cure Is Possible: Extensively Metastatic HER2-Positive Gastric Carcinoma with 5 years of Complete Remission after Therapy with the FLOT Regimen and TrastuzumabSebastian Schade, Ute Koenig, Ardian Mekolli, et al.
Pageof 28